Hitachi Exhibits 64-slice SCENARIA with Advanced Dose Reduction Technology at RSNA
"SCENARIA goes beyond being just another versatile 64-slice CT, by including unique dose reduction features for its segment, such as combining a lateral-shifting table-top with a smaller x-ray bow-tie filter, to provide both improved resolution and reduced dose," said Mark Silverman, Manager of CT Marketing. "And, SCENARIA offers a breadth of other important features, including Intelli EC -Exposure Control and Intelli IP -Iterative Processing for dose reduction, together an enlarged 75cm gantry aperture, for greater access and comfort."
Considering that published clinical studies demonstrate 64-slice CT has a 99% negative predictive value in excluding Major Cardiac Adverse Events (MACE) for 30 days in patients who present with acute coronary syndrome (ACS), 64-slice CT fulfills most providers CT needs for lower dose with routine and advanced cardiac applications, without the added financial burden of purchasing a dramatically higher cost, higher slice CT system.
SCENARIA also excels in 3D visualization and analysis capabilities critical to physicians, by offering an integrated TeraRecon iNtuition® server with a full range of advanced clinical applications that are simultaneously available to multiple users.
About Hitachi Medical Systems America, Inc.
Hitachi Medical Systems America (HMSA) located in Twinsburg, Ohio, a wholly owned subsidiary of Hitachi Medical Corporation offers a broad range of diagnostic imaging equipment including MRI, CT and Ultrasound. Our innovations in diagnostic imaging provide technology that drives clinical solutions to deliver diagnostic confidence, improve workflow efficiency and provide a better patient experience. In addition to exceptional equipment, HMSA is known for its comprehensive customer support programs to maximize the lifecycle value of equipment through responsive service maintenance, significant software upgrades and on-going applications support.
About Hitachi, Ltd.
Hitachi, Ltd., (NYSE: HIT)(TOKYO: 6501), headquartered in Tokyo, Japan, is a leading global electronics company with approximately 362,000 employees worldwide on the consolidated basis. Fiscal 2010 (ended March 31, 2011) consolidated revenues totaled 9,316 billion yen ($110.9 billion). Hitachi will focus more than ever on the Social Innovation Business, which includes Information and Telecommunication Systems, Power Systems, Industrial, Transportation and Urban Development Systems, as well as the sophisticated Materials and Key Devices that support them.
*In clinical use, dose saving features may reduce CT patient dose depending on the clinical task, patient size, anatomical location and clinical practices employed. Consultation with a radiologist and physicist are recommended to determine the appropriate dose needed to obtain diagnostic image quality for a particular clinical task.